CAPS vs TECH
Capstone Holding Corp. Common Stock (CAPS) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Capstone Holding Corp. Common Stock (CAPS) is a building materials company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported CAPS revenue for 2024-12-31 was $45.8M. Net income was -$2.6M. Revenue was down 5.8% from 2023-12-31 to 2024-12-31. CAPS currently screens at market cap $3.7M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
CAPS currently screens at market cap $3.7M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the CAPS and TECH stock pages for the full models.
Not investment advice.